David Bhatt

David Bhatt focuses on the epidemiology, molecular biology, and prevention of esophageal adenocarcinoma arising from Barrett's esophagus. His research has characterized the genomic evolution from Barrett's metaplasia through dysplasia to invasive adenocarcinoma, identifying molecular events driving neoplastic progression. He has evaluated biomarker strategies and endoscopic surveillance protocols for detecting high-grade dysplasia in Barrett's patients. His translational work has contributed to endoscopic eradication therapies for early esophageal adenocarcinoma and guidelines for Barrett's management.